1
Disruption of this process contributes to barrier compromise and mucosal inflammatory diseases.
2
Background: Transcription factor NF-kappaB has been implicated in numerous human inflammatory diseases.
3
Our results propose SP as a candidate therapeutic for intestine-related inflammatory diseases.
4
MRI often allows the differential diagnosis between inflammatory diseases and malignant tumors.
5
Pathogenic Th17 cells play important roles in many autoimmune and inflammatory diseases.
6
These disease entities may be differentiated into congenital, acquired and inflammatory diseases.
7
Failure of resolution contributes to the pathology of numerous chronic inflammatory diseases.
8
Like other inflammatory diseases, there is sexual dimorphism evident in periodontal diseases.
9
We propose Nrf2 inducers as a future treatment option in STING-dependent inflammatory diseases.
10
Background: Systemic inflammatory diseases have been associated with increased risk of venous thromboembolism.
11
The majority of risk factors for chronic inflammatory diseases are unknown.
12
However, its pathophysiological significance in intestinal inflammatory diseases has just started to emerge.
13
Background and purpose: Glucocorticoids are highly effective in the therapy of inflammatory diseases.
14
These data support targeting this receptor for the treatment of chronic inflammatory diseases.
15
Apoptosis of matrix producing cells is common among many inflammatory diseases.
16
Remission is less frequently achieved when systemic inflammatory diseases are present.
